Corrigendum to "Outcomes of Living Kidney Donors Following Donor Nephrectomy in Aotearoa New Zealand" [Volume 10, Issue 3, March 2025, Pages 762-771].
「更正啟事：Aotearoa New Zealand 活體腎臟捐贈者於捐腎手術後之預後分析」【第10卷，第3期，2025年3月，頁762-771】
Kidney Int Rep 2025-06-09
Corrigendum to "WCN24-2221 NEPHROCALCINOSIS AND LOWER LIMBS TISSUE NECROSIS DUE TO CALCIUM OXALATE DEPOSITS IN A 24-YEAR-OLD PATIENT WITH STAGE 5 CHRONIC KIDNEY DISEASE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S656-S657].
更正：「WCN24-2221 24歲患有第5期慢性腎臟病患者因鈣草酸鹽沉積導致腎鈣化和下肢組織壞死」一文 [<i>Kidney International Reports</i> 2024年4月第9卷第4期補充刊，第S656-S657頁]。
Kidney Int Rep 2024-06-20
Corrigendum to "WCN24-1675 ACUTE NECROTIZING ULCERATIVE GENGIVITIS IN KIDNEY TRANSPLANTATION: A CASE REPORT" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S473].
更正：「WCN24-1675 腎移植中急性壞死性潰瘍性牙齦炎：一個病例報告」 [<i>Kidney International Reports</i> 2024年4月第9卷第4期，補充資料，第S473頁]。
Kidney Int Rep 2024-06-20
Corrigendum to "WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S86].
對於「WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，第S86頁]。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-1709 NON-CADAVERIC HOMOLOGOUS VEIN AS VASCULAR ACCESS IN A PATIENT WITH EXHAUSTED NATIVE VEINS ON HEMODIALYSIS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Pages S398-S399].
對於「WCN24-1709 非屍體同源靜脈作為一名在透析中原生靜脈耗竭患者的血管通路」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，頁S398-S399]。
Kidney Int Rep 2024-08-19
Corrigendum to "WCN24-2021 KNOWLEDGE ATTITUDES AND BELIEFS ABOUT KIDNEY TRANSPLANTATION IN JAMAICAN RESIDENTS" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S482].
對於「WCN24-2021 牙買加居民對腎臟移植的知識、態度和信念」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，頁S482]。
Kidney Int Rep 2024-08-19
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、找到這篇文章，或是其他相關的問題，請提供更多細節！
PubMedDOI
Corrigendum to "Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia" [<i>Kidney International Reports</i> Volume 9, Issue 5, May 2024, Pages 1419-1428].
對於「Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia」的更正 [<i>Kidney International Reports</i> 第9卷，第5期，2024年5月，頁1419-1428]。
Kidney Int Rep 2025-02-24
Corrigendum to "WCN25-3808 NAFLD IN ESRD - PREVALENCE OF NAFLD in ESRD PATIENTS AND EVALUATION OF THERAPEUTIC EFFICACY OF TOCOTRIENOL IN TREATMENT OF NAFLD" [<i>Kidney International Reports</i> Volume 10, Issue 2, Supplement, February 2025, Pages S339-S340].
更正啟事：「WCN25-3808 末期腎臟病（ESRD）中的非酒精性脂肪肝病（NAFLD）—ESRD 患者中 NAFLD 的盛行率及 tocotrienol 治療 NAFLD 療效之評估」[《Kidney International Reports》2025年2月，第10卷，第2期，增刊，S339-S340頁]
Kidney Int Rep 2025-04-30
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226].
更正啟事：「ALIGN 隨機對照研究 Atrasentan 用於 IgA Nephropathy 患者之研究設計與基線特徵」[第10卷，第1期，2025年1月，頁217-226]
Kidney Int Rep 2025-04-30
重點摘要：
這則通知是用來更正 DOI 為 10.1016/j.ekir.2024.10.004 的文章。內容很可能是針對該篇發表的錯誤進行修正，或是提供相關的最新更新。
PubMedDOI
Corrigendum to "PREGNANCY AS A WINDOW TO CURRENT AND FUTURE KIDNEY HEALTH-AN OPPORTUNITY" [Volume 10, Issue 3, March 2025, Pages 645-649].
「PREGNANCY AS A WINDOW TO CURRENT AND FUTURE KIDNEY HEALTH-AN OPPORTUNITY」[第10卷，第3期，2025年3月，第645-649頁]之更正啟事
Kidney Int Rep 2025-06-09
Corrigendum to "SAT-040 RENAL SAFETY OF DIRECT ACTING ANTIVIRAL DRUGS IN POST LIVER TRANSPLANT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION" [Volume 5, Issue 3, Supplement, March 2020, Pages S18-S19].
「SAT-040 直接作用型抗病毒藥物於肝臟移植後慢性 C 型肝炎患者之腎臟安全性」更正啟事 [第5卷，第3期，增刊，2020年3月，S18-S19頁]
Kidney Int Rep 2025-06-09